Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Sanovas Inc. Stories

2012-07-25 02:29:18

SAUSALITO, Calif., July 25, 2012 /PRNewswire/ -- Sanovas Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today the formation of a scientific advisory board to support the development of its Vas Zeppelin(TM) Smart Catheter portfolio, which will initially be commercialized for lung cancer and pulmonary disease. The company appointed Stephen C. Schimpff, MD, an...

2012-06-14 06:24:42

SAUSALITO, Calif., June 14, 2012 /PRNewswire/ -- Sanovas, Inc., a medical technology company focused on developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent relating to systems and methods for the removal of unwanted biological material, such as tissue growths and tumors, in hard-to-reach bodily...

2012-06-12 02:25:59

MOUNTAIN VIEW, Calif., June 12, 2012 /PRNewswire/ -- Based on its recent analysis of the pulmonary disease treatment market, Frost & Sullivan recognizes Sanovas, Inc. with the 2012 North American Frost & Sullivan Award for New Product Innovation. Sanovas's pioneering Vas Zeppelin microsurgery technology platform represents a major leap forward in the tools available to diagnose and treat lung cancer and other airway obstructions. The increasing incidence of pulmonary...

2012-01-24 11:58:00

SAUSALITO, Calif., Jan. 24, 2012 /PRNewswire/ -- Sanovas CEO Larry Gerrans will participate in a panel titled "Fundraising in Troubled Times" as part of BayBio's Life Sciences Series on Thursday, Jan. 26 at 8 a.m. in Palo Alto. The event will take place at the Silicon Valley offices of DLA Piper. Gerrans will speak about alternative approaches to funding and the emerging trends and opportunities in business financing, including the proposed legislative changes to the laws that currently...

2012-01-24 07:00:00

SAUSALITO, Calif., Jan. 24, 2012 /PRNewswire/ -- Sanovas, a leading developer of innovative micro-surgical devices for diagnosing and treating cancer and chronic diseases, announced today that it has expanded its corporate headquarters and opened a manufacturing site in Sausalito, Calif. The facility will initially manufacture critical components of Sanovas' technology ahead of filing for U.S. Food and Drug Administration approval, and would ultimately serve to produce Sanovas'...

2011-11-21 07:10:00

CORAL SPRINGS, Fla., Nov. 21, 2011 /PRNewswire/ -- The Producers of Profiles with Terry Bradshaw are pleased to announce that Sanovas will be featured in an upcoming segment on topics, trends, and issues related to "Improving Clinical Outcomes through Technology" as part of the show's "Medical Minutes" series. Lung cancer is the most common form of cancer globally, with new cases increasing by more than 40% a year. In the U.S., there are more deaths caused by lung cancer than all other...

2011-09-22 07:00:00

SAUSALITO, Calif., Sept. 22, 2011 /PRNewswire/ -- Sanovas Inc., a leading developer of minimally invasive technologies for the diagnosis and treatment of pulmonary disease and lung cancer, today announced that CEO and co-founder Larry Gerrans will speak at AdvaMed 2011, the industry's premier medical technology conference taking place Sept. 26-28, 2011 in Washington, D.C. Mr. Gerrans, an industry veteran, will be participating in an interactive panel addressing the challenges and lessons...